Vertex Pharmaceuticals (VRTX)

EBITDA Margin

43.60%

TTM · Period ending:

VRTX logo

VRTX EBITDA Margin

Latest reported43.60%
VRTX TTM EBITDA Margin (-178.26% → 43.60%)
High-resolution chart · PNG

VRTX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
43.5953%
44.0086%
40.4231%
39.7559%
40.1916%
-0.6874%
4.4015%
4.8737%
4.5007%
49.172%
46.6623%
46.7651%
47.4424%
47.4761%
49.6658%
48.6005%
49.4754%
38.4734%
38.519%
41.1244%
38.7313%
53.8037%
52.9267%
51.2033%
44.2807%
39.3543%
37.4833%
24.8367%
27.5532%
25.3235%
23.1914%
27.9982%
9.1464%
2.4927%
4.1492%
0.7855%
18.8651%
17.5408%
4.2146%
-1.4508%
-4.8132%
-19.1213%
-39.5894%
-67.2146%
-93.003%
-101.5936%
-112.1527%
-117.0592%
-108.6329%
-76.5355%
-82.1726%
-54.3529%
-40.629%
-34.3753%
2.7744%
19.371%
26.3241%
21.5719%
9.0206%
-33.6509%
-260.3327%
-372.9948%
-503.9688%
-581.9645%
-523.7641%
-568.13%
-569.2774%
-577.8129%
-524.5015%
-315.2394%
-242.8366%
-195.4524%
-178.6646%
-231.892%
-193.5632%
-135.4768%
-108.7904%
-93.8857%
-92.2179%
-99.858%
-97.5873%
-76.6349%
-74.1109%
-92.1267%
-93.3592%
-99.8454%
-104.747%
-258.2696%
-381.8228%
-463.1978%
-361.3543%
-170.011%
-99.7801%
-37.8919%
-58.4611%
-44.569%
-34.1354%
-36.5855%
-36.5911%
-52.4102%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.